Muki Rapp

Muki Rapp's Title

Muki Rapp serves as the Executive Vice President of Research and Product Development at Notal Vision. In this pivotal role, he oversees the strategic direction and execution of innovative product developments and research initiatives. His leadership is instrumental in guiding the company towards groundbreaking advancements in eye care technology, ensuring that Notal Vision remains at the forefront of the industry.

Muki Rapp's Company

Muki Rapp joined Notal Vision, a pioneering ophthalmic diagnostic services company, close to its inception in 2001. Notal Vision is renowned for its innovative approach to eye care, particularly in the development of home-based diagnostic solutions such as the ForeseeHome AMD Monitoring Program. Under Rapp's guidance, the company has continued to push the boundaries of technology in ophthalmology, developing pipeline technologies that aim to transform the way eye diseases are monitored and managed.

Muki Rapp's Education and Expertise

Muki Rapp holds a PhD and MSc in neuroscience, which provide a robust foundation for his work in medical and diagnostic technologies. Additionally, he earned a BSc in computer science from the Hebrew University of Jerusalem, Israel. His educational background combines a deep understanding of brain function with advanced technical skills, enabling him to innovate at the intersection of technology and healthcare.

Muki Rapp's Background

Before joining Notal Vision, Muki Rapp had an extensive career as a senior software engineer. He worked on developing virtual reality solutions for TV broadcast and active eBusiness intelligence solutions. This experience in cutting-edge technologies provided him with the skills and insights necessary to drive forward-thinking projects at Notal Vision. His transition from software engineering to medical technology demonstrates his versatile expertise and adaptability.

Muki Rapp's Achievements

One of Muki Rapp's notable achievements at Notal Vision includes managing the development and commercialization of the ForeseeHome AMD Monitoring Program. This program has significantly impacted the early detection and monitoring of age-related macular degeneration (AMD), helping to preserve vision for many patients. Rapp's leadership in bringing this product to market underscores his capability to translate complex research into practical, life-changing applications.